phagos

We founded Phagos out of a common ideal: to use entrepreneurship as a force for positive change. Antibiotic resistance is an urgent and unaddressed global challenge that was declared a top 10 threat to humanity by the World Health Organisation. Experts project that this silent pandemic could kill 10 million people per year by 2050. At Phagos, were dedicated to finding a solution. Our approach is evolutionarywe harness the natural predator of bacteria, the bacteriophage, to cure these life-threatening infectious diseases. Bacteriophages can become an efficient and sustainable alternative to antibiotics. But this is just a fraction of their potential....

Phage therapy,biomimetics,and animal health

Phagos operates in the Biotechnology research industry.

Phagos's revenue is 11m - 100m

Phagos has 11 - 50 employees.